Under the Medical Device Act 2012 (737) in Malaysia, medical device registration with the Medical Device Authority (MDA) is required for all medical devices manufactured, imported, or sold in the country.
Pure Global simplifies the process with AI workflows that accelerate MDA submission preparation, along with local support and representation, all for a flat annual fee.

Malaysia’s medical devices market will reach $4.46B by 2029 (7.12% CAGR), and the IVD market$346.5M (4.27% CAGR). Growth is driven by rising healthcare spending, heavy reliance on imports (95%), and digital health expansion.

Medical device and IVD registration in Malaysia is overseen by the Medical Device Authority (MDA) under the Ministry of Health.
The system is based on the Medical Device Act 2012, Medical Device Authority Act 2012, and Medical Device Regulations 2012. Most devices require a conformity assessment by a Malaysian Conformity Assessment Body (CAB) before registration. Class A devices are exempt from CAB assessment.
Registration applications are submitted through Malaysia’s MeDC@St system, and all devices must comply with labeling and postmarket surveillance obligations to maintain market authorization.
Devices are classified into Class A, B, C, and D based on risk. IVDs follow a parallel scheme from Class A through D. Classification determines registration and conformity assessment requirements.
All devices except Class A require conformity assessment by a CAB. There are two regulatory pathways:
Verification (abridged) review: For devices already approved in the EU, UK, Australia, Canada, Japan, Singapore, Thailand, or the US. These devices undergo a shorter review, provided reference-country evidence is supplied.
Full conformity assessment: Required for devices without reference market approval. This process mirrors an EU notified body assessment and includes technical documentation review, QMS verification, and audit.
Once CAB certification is complete, manufacturers apply for registration through MeDC@St.
Foreign manufacturers must appoint a Malaysian Authorized Representative (AR). The AR holds the registration, interacts with MDA, submits applications and modifications, maintains device records, and ensures postmarket surveillance compliance. The AR is also responsible for submitting renewals, reporting adverse events, and coordinating recalls or field corrective actions when necessary.
An establishment license is the MDA’s required operating license for any entity that places medical devices on the Malaysian market. Under the Medical Device Act 2012, only a licensed “establishment” can import, export, manufacture, or distribute a registered device. Establishments include manufacturers, authorized representatives, importers, and distributors.
If you’re a foreign manufacturer, you don’t hold this license yourself unless you have a Malaysian legal entity. You must appoint a local authorized representative that is licensed as an establishment.
We provide turnkey regulatory support in Malaysia, all for a flat annual fee:
Dossier preparation and submission, powered by AI-assisted workflows and regulatory experts.
In-country representation, with Pure Global serving as your Authorized Representative to the MDA.
Post-market surveillance support, including vigilance reporting and authority communications.
Importer authorizations, post-approval modifications, and renewals.

MDA charges mandatory government fees based on device risk classification, with fees assessed per product. There are application fees and registration fees.
Application fees are as follows:
Registration fees are charged in addition to the application fee:
Conformity Assessment Body (CAB) review fees apply as well, and these vary depending on the CAB and scope of assessment.
The fees listed do not include consulting services, dossier preparation, testing, CAB charges, or local regulatory representation. Government fees and CAB fees may change without notice.
Check our Fee Calculator for up-to-date government fees in 14 markets.
Malaysia uses a risk-based classification system for medical devices. This classification, regulated by the Medical Device Authority, Ministry of Health Malaysia, determines the complexity of the required technical documentation and whether a Conformity Assessment Body (CAB) review is necessary.
Yes, according to the Medical Device Act 2012 (Act 737), all medical devices that are manufactured, imported, or sold in Malaysia must be registered with the MDA. This registration process includes adhering to the MDA classification system.
Foreign manufacturers must appoint a local Authorized Representative (AR) to handle regulatory submissions and liaise with the Medical Device Authority, Ministry of Health Malaysia. The AR must hold an establishment license and Good Distribution Practice for Medical Devices (GDPMD) certification. Additionally, the technical documentation must undergo a review by a Conformity Assessment Body (CAB) before submission to the MDA.
When you partner with Pure Global, a single registration process opens doors to multiple countries. Our global subsidiaries make this streamlined path possible.
Whether looking for more information or ready to partner with us, we're here to guide you through every step of the regulatory process.
Contact us